Hepatitis B Virus Core 128-140

Hepatitis B Virus Core 128-140 is a synthetic peptide fragment corresponding to amino acids 128 to 140 of the hepatitis B virus (HBV) core antigen. As a well-defined peptide epitope, it plays a critical role in virology research, particularly in studies focused on HBV structure, immune recognition, and viral-host interactions. The sequence represents a region of the HBV core protein known to be involved in immunological processes, making it a valuable reagent for fundamental and applied research into viral pathogenesis, immune response mapping, and the development of diagnostic tools. Its precise sequence and biochemical stability enable researchers to conduct reproducible experiments, supporting robust scientific investigation into HBV biology.

Epitope mapping: Utilization of the 128-140 core peptide fragment enables detailed analysis of antibody binding sites within the HBV core antigen. Researchers can employ it in immunoassays such as ELISA, western blotting, or peptide microarrays to identify and characterize specific B-cell or T-cell epitopes. Such studies are fundamental for understanding humoral and cellular immune responses to HBV infection, as well as for the assessment of immune memory and vaccine-induced recognition. By providing a defined antigenic determinant, the peptide facilitates the dissection of epitope-specific interactions crucial for immunological research.

Immunogenicity studies: The peptide serves as a model antigen for evaluating immune responses in experimental systems. It can be used to stimulate lymphocytes in vitro, enabling researchers to assess T-cell reactivity, cytokine production, and activation profiles associated with HBV exposure. These applications are vital for elucidating mechanisms of viral clearance or persistence, and for identifying immunodominant regions that may inform rational vaccine design or immunotherapeutic development. Its defined sequence ensures specificity and reproducibility in immunological assays.

Diagnostic assay development: Synthetic peptides derived from the HBV core region, such as the 128-140 fragment, are instrumental in the development of serological assays for the detection of HBV-specific antibodies. Incorporation of this peptide into assay platforms enhances the specificity and sensitivity of diagnostic tools by targeting immunologically relevant sequences. Such assays are essential for epidemiological studies, blood screening, and monitoring immune status in research settings. The use of well-characterized peptide antigens supports high-quality assay performance and reliable data interpretation.

Peptide-structure and function studies: The 128-140 core sequence provides a model system for investigating the structural and functional properties of HBV core protein regions. Researchers can employ the peptide in biophysical analyses, such as circular dichroism spectroscopy or nuclear magnetic resonance, to explore secondary structure tendencies and conformational dynamics. Insights gained from such studies contribute to the broader understanding of HBV core protein assembly, stability, and its role in the viral lifecycle.

Antibody production and validation: The defined peptide fragment can serve as an immunogen for generating polyclonal or monoclonal antibodies specific to the HBV core region. These antibodies are valuable reagents for a variety of downstream applications, including immunodetection, affinity purification, and mechanistic studies of viral protein function. The use of a synthetic peptide as an immunogen ensures epitope specificity and consistency, supporting the development of high-quality antibody tools for HBV research.

1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

2. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

3. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries